MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

09 May 2026 Evaluate
The Revenue for the quarter ended  March 2026 of Rs. 1497.68 millions grew by 10.60 % from Rs. 1354.14 millions.A slim rise of 6.69% was recorded in the Net profit for the quarter ended March 2026 to Rs. 161.94  millions  From Rs. 151.78 millions.OP of the company witnessed a marginal growth to 302.74 millions from 225.21 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1497.68 1354.14 10.60 5025.53 4518.16 11.23 5025.53 4518.16 11.23
Other Income 47.31 48.19 -1.83 175.74 176.79 -0.59 175.74 176.79 -0.59
PBIDT 302.74 225.21 34.43 932.59 758.79 22.90 932.59 758.79 22.90
Interest 0.46 0.43 6.98 1.95 2.19 -10.96 1.95 2.19 -10.96
PBDT 226.23 224.78 0.65 842.07 756.60 11.30 842.07 756.60 11.30
Depreciation 16.06 16.22 -0.99 63.19 65.26 -3.17 63.19 65.26 -3.17
PBT 210.17 208.56 0.77 778.88 691.34 12.66 778.88 691.34 12.66
TAX 48.23 56.78 -15.06 199.70 182.99 9.13 199.70 182.99 9.13
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 161.94 151.78 6.69 579.18 508.35 13.93 579.18 508.35 13.93
Equity 28.91 28.91 0.00 28.91 28.91 0.00 28.91 28.91 0.00
PBIDTM(%) 20.21 16.63 21.54 18.56 16.79 10.50 18.56 16.79 10.50
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..